Selected research
Industry Research
Stool Biomarkers Test Industry Research Report 2026
Market perspective
The global Stool Biomarkers Test market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Stool Biomarkers Test market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Stool Biomarkers Test market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Stool Biomarkers Test market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Stool Biomarkers Test include Genova Diagnostics, BioMrieux Inc, Actim, DiaSorin S.p.A., Beckman Coulter Inc., Alere Inc., Bio Rad Laboratories, Cenogenics Corporation and Siemens Healthcare, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Stool Biomarkers Test market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Stool Biomarkers Test.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Stool Biomarkers Test Market by Company
Genova Diagnostics
BioMrieux Inc
Actim
DiaSorin S.p.A.
Beckman Coulter Inc.
Alere Inc.
Bio Rad Laboratories
Cenogenics Corporation
Siemens Healthcare
Quest Diagnostics Incorporated
Abbott Laboratories
Diagnose IBS
Meridian Bioscience Inc
Stool Biomarkers Test Segment by Type
Cologuard
M2 PK Stool Test
Others
Stool Biomarkers Test Segment by Application
Hospitals
Diagnostic Centres and Laboratories
Academic Institutions
Research Centres and Organizations
Stool Biomarkers Test Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stool Biomarkers Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Stool Biomarkers Test and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stool Biomarkers Test.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Stool Biomarkers Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cologuard
- M2 PK Stool Test
- Others
Applications
- Hospitals
- Diagnostic Centres and Laboratories
- Academic Institutions
- Research Centres and Organizations
Companies covered
- Genova Diagnostics
- BioMrieux Inc
- Actim
- DiaSorin S.p.A.
- Beckman Coulter Inc.
- Alere Inc.
- Bio Rad Laboratories
- Cenogenics Corporation
- Siemens Healthcare
- Quest Diagnostics Incorporated
- Abbott Laboratories
- Diagnose IBS
- Meridian Bioscience Inc
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Stool Biomarkers Test by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cologuard
- 2.2.3 M2 PK Stool Test
- 2.2.4 Others
- 2.3 Stool Biomarkers Test by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Diagnostic Centres and Laboratories
- 2.3.4 Academic Institutions
- 2.3.5 Research Centres and Organizations
- 2.4 Assumptions and Limitations
3 Stool Biomarkers Test Breakdown Data by Type
- 3.1 Global Stool Biomarkers Test Historic Market Size by Type (2021-2026)
- 3.2 Global Stool Biomarkers Test Forecasted Market Size by Type (2027-2032)
4 Stool Biomarkers Test Breakdown Data by Application
- 4.1 Global Stool Biomarkers Test Historic Market Size by Application (2021-2026)
- 4.2 Global Stool Biomarkers Test Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Stool Biomarkers Test Market Perspective (2021-2032)
- 5.2 Global Stool Biomarkers Test Growth Trends by Region
- 5.2.1 Global Stool Biomarkers Test Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Stool Biomarkers Test Historic Market Size by Region (2021-2026)
- 5.2.3 Stool Biomarkers Test Forecasted Market Size by Region (2027-2032)
- 5.3 Stool Biomarkers Test Market Dynamics
- 5.3.1 Stool Biomarkers Test Industry Trends
- 5.3.2 Stool Biomarkers Test Market Drivers
- 5.3.3 Stool Biomarkers Test Market Challenges
- 5.3.4 Stool Biomarkers Test Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Stool Biomarkers Test Players by Revenue
- 6.1.1 Global Top Stool Biomarkers Test Players by Revenue (2021-2026)
- 6.1.2 Global Stool Biomarkers Test Revenue Market Share by Players (2021-2026)
- 6.2 Global Stool Biomarkers Test Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Stool Biomarkers Test Head Office and Area Served
- 6.4 Global Stool Biomarkers Test Players, Product Type & Application
- 6.5 Global Stool Biomarkers Test Manufacturers Established Date
- 6.6 Global Stool Biomarkers Test Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Stool Biomarkers Test Market Size (2021-2032)
- 7.2 North America Stool Biomarkers Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Stool Biomarkers Test Market Size by Country (2021-2026)
- 7.4 North America Stool Biomarkers Test Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Stool Biomarkers Test Market Size (2021-2032)
- 8.2 Europe Stool Biomarkers Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Stool Biomarkers Test Market Size by Country (2021-2026)
- 8.4 Europe Stool Biomarkers Test Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Stool Biomarkers Test Market Size (2021-2032)
- 9.2 Asia-Pacific Stool Biomarkers Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Stool Biomarkers Test Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Stool Biomarkers Test Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Stool Biomarkers Test Market Size (2021-2032)
- 10.2 South America Stool Biomarkers Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Stool Biomarkers Test Market Size by Country (2021-2026)
- 10.4 South America Stool Biomarkers Test Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Stool Biomarkers Test Market Size (2021-2032)
- 11.2 Middle East & Africa Stool Biomarkers Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Stool Biomarkers Test Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Stool Biomarkers Test Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Genova Diagnostics
- 12.1.1 Genova Diagnostics Company Information
- 12.1.2 Genova Diagnostics Business Overview
- 12.1.3 Genova Diagnostics Revenue in Stool Biomarkers Test Business (2021-2026)
- 12.1.4 Genova Diagnostics Stool Biomarkers Test Product Portfolio
- 12.1.5 Genova Diagnostics Recent Developments
- 12.2 BioMrieux Inc
- 12.2.1 BioMrieux Inc Company Information
- 12.2.2 BioMrieux Inc Business Overview
- 12.2.3 BioMrieux Inc Revenue in Stool Biomarkers Test Business (2021-2026)
- 12.2.4 BioMrieux Inc Stool Biomarkers Test Product Portfolio
- 12.2.5 BioMrieux Inc Recent Developments
- 12.3 Actim
- 12.3.1 Actim Company Information
- 12.3.2 Actim Business Overview
- 12.3.3 Actim Revenue in Stool Biomarkers Test Business (2021-2026)
- 12.3.4 Actim Stool Biomarkers Test Product Portfolio
- 12.3.5 Actim Recent Developments
- 12.4 DiaSorin S.p.A.
- 12.4.1 DiaSorin S.p.A. Company Information
- 12.4.2 DiaSorin S.p.A. Business Overview
- 12.4.3 DiaSorin S.p.A. Revenue in Stool Biomarkers Test Business (2021-2026)
- 12.4.4 DiaSorin S.p.A. Stool Biomarkers Test Product Portfolio
- 12.4.5 DiaSorin S.p.A. Recent Developments
- 12.5 Beckman Coulter Inc.
- 12.5.1 Beckman Coulter Inc. Company Information
- 12.5.2 Beckman Coulter Inc. Business Overview
- 12.5.3 Beckman Coulter Inc. Revenue in Stool Biomarkers Test Business (2021-2026)
- 12.5.4 Beckman Coulter Inc. Stool Biomarkers Test Product Portfolio
- 12.5.5 Beckman Coulter Inc. Recent Developments
- 12.6 Alere Inc.
- 12.6.1 Alere Inc. Company Information
- 12.6.2 Alere Inc. Business Overview
- 12.6.3 Alere Inc. Revenue in Stool Biomarkers Test Business (2021-2026)
- 12.6.4 Alere Inc. Stool Biomarkers Test Product Portfolio
- 12.6.5 Alere Inc. Recent Developments
- 12.7 Bio Rad Laboratories
- 12.7.1 Bio Rad Laboratories Company Information
- 12.7.2 Bio Rad Laboratories Business Overview
- 12.7.3 Bio Rad Laboratories Revenue in Stool Biomarkers Test Business (2021-2026)
- 12.7.4 Bio Rad Laboratories Stool Biomarkers Test Product Portfolio
- 12.7.5 Bio Rad Laboratories Recent Developments
- 12.8 Cenogenics Corporation
- 12.8.1 Cenogenics Corporation Company Information
- 12.8.2 Cenogenics Corporation Business Overview
- 12.8.3 Cenogenics Corporation Revenue in Stool Biomarkers Test Business (2021-2026)
- 12.8.4 Cenogenics Corporation Stool Biomarkers Test Product Portfolio
- 12.8.5 Cenogenics Corporation Recent Developments
- 12.9 Siemens Healthcare
- 12.9.1 Siemens Healthcare Company Information
- 12.9.2 Siemens Healthcare Business Overview
- 12.9.3 Siemens Healthcare Revenue in Stool Biomarkers Test Business (2021-2026)
- 12.9.4 Siemens Healthcare Stool Biomarkers Test Product Portfolio
- 12.9.5 Siemens Healthcare Recent Developments
- 12.10 Quest Diagnostics Incorporated
- 12.10.1 Quest Diagnostics Incorporated Company Information
- 12.10.2 Quest Diagnostics Incorporated Business Overview
- 12.10.3 Quest Diagnostics Incorporated Revenue in Stool Biomarkers Test Business (2021-2026)
- 12.10.4 Quest Diagnostics Incorporated Stool Biomarkers Test Product Portfolio
- 12.10.5 Quest Diagnostics Incorporated Recent Developments
- 12.11 Abbott Laboratories
- 12.11.1 Abbott Laboratories Company Information
- 12.11.2 Abbott Laboratories Business Overview
- 12.11.3 Abbott Laboratories Revenue in Stool Biomarkers Test Business (2021-2026)
- 12.11.4 Abbott Laboratories Stool Biomarkers Test Product Portfolio
- 12.11.5 Abbott Laboratories Recent Developments
- 12.12 Diagnose IBS
- 12.12.1 Diagnose IBS Company Information
- 12.12.2 Diagnose IBS Business Overview
- 12.12.3 Diagnose IBS Revenue in Stool Biomarkers Test Business (2021-2026)
- 12.12.4 Diagnose IBS Stool Biomarkers Test Product Portfolio
- 12.12.5 Diagnose IBS Recent Developments
- 12.13 Meridian Bioscience Inc
- 12.13.1 Meridian Bioscience Inc Company Information
- 12.13.2 Meridian Bioscience Inc Business Overview
- 12.13.3 Meridian Bioscience Inc Revenue in Stool Biomarkers Test Business (2021-2026)
- 12.13.4 Meridian Bioscience Inc Stool Biomarkers Test Product Portfolio
- 12.13.5 Meridian Bioscience Inc Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst